Mostrando 30,801 - 30,820 Resultados de 30,895 Para Buscar '"boxing"', tiempo de consulta: 0.31s Limitar resultados
  1. 30801
    “…CYP2D6 substrates were categorized as those with the potential for increased risk of QT prolongation, with anticholinergic properties, with narrow therapeutic index (NTI), contraindicated or having a black box warning when used with CYP2D6 inhibitors, or used for depression or other psychiatric disease. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  2. 30802
    por Rustamkulov, Z., Sing, D. K., Mukherjee, S., May, E. M., Kirk, J., Schlawin, E., Line, M. R., Piaulet, C., Carter, A. L., Batalha, N. E., Goyal, J. M., López-Morales, M., Lothringer, J. D., MacDonald, R. J., Moran, S. E., Stevenson, K. B., Wakeford, H. R., Espinoza, N., Bean, J. L., Batalha, N. M., Benneke, B., Berta-Thompson, Z. K., Crossfield, I. J. M., Gao, P., Kreidberg, L., Powell, D. K., Cubillos, P. E., Gibson, N. P., Leconte, J., Molaverdikhani, K., Nikolov, N. K., Parmentier, V., Roy, P., Taylor, J., Turner, J. D., Wheatley, P. J., Aggarwal, K., Ahrer, E., Alam, M. K., Alderson, L., Allen, N. H., Banerjee, A., Barat, S., Barrado, D., Barstow, J. K., Bell, T. J., Blecic, J., Brande, J., Casewell, S., Changeat, Q., Chubb, K. L., Crouzet, N., Daylan, T., Decin, L., Désert, J., Mikal-Evans, T., Feinstein, A. D., Flagg, L., Fortney, J. J., Harrington, J., Heng, K., Hong, Y., Hu, R., Iro, N., Kataria, T., Kempton, E. M.-R., Krick, J., Lendl, M., Lillo-Box, J., Louca, A., Lustig-Yaeger, J., Mancini, L., Mansfield, M., Mayne, N. J., Miguel, Y., Morello, G., Ohno, K., Palle, E., Petit dit de la Roche, D. J. M., Rackham, B. V., Radica, M., Ramos-Rosado, L., Redfield, S., Rogers, L. K., Shkolnik, E. L., Southworth, J., Teske, J., Tremblin, P., Tucker, G. S., Venot, O., Waalkes, W. C., Welbanks, L., Zhang, X., Zieba, S.
    Publicado 2023
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  3. 30803
    “…Specific immune cells including proportion of T cells (p = 0.04) and CD4(+) T cells in lymphocytes (p = 0.03), and CD4+ CD25+ forkhead box protein 3 (FoxP3)+ regulatory T cells in CD4+ T cells increased significantly after ACBMNCs intervention (p < 0.001). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  4. 30804
    por Rajeev, S, Li, S, Flannigan, K, Wang, A, McKay, D M
    Publicado 2023
    “…PLEASE ACKNOWLEDGE ALL FUNDING AGENCIES BY CHECKING THE APPLICABLE BOXES BELOW: Other PLEASE INDICATE YOUR SOURCE OF FUNDING; NSERC, , Eyes High doctoral scholarship, Alberta Graduate excellence scholarship DISCLOSURE OF INTEREST: None Declared…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  5. 30805
    “…PLEASE ACKNOWLEDGE ALL FUNDING AGENCIES BY CHECKING THE APPLICABLE BOXES BELOW: None DISCLOSURE OF INTEREST: T. Barnett Grant / Research support from: AbbVie, Gilead, Merck, M. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  6. 30806
  7. 30807
    “…PLEASE ACKNOWLEDGE ALL FUNDING AGENCIES BY CHECKING THE APPLICABLE BOXES BELOW: CIHR, Other PLEASE INDICATE YOUR SOURCE OF FUNDING; Society for the Study of Celiac Disease (Nestle); Canadian Digestive Health Foundation DISCLOSURE OF INTEREST: None Declared…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  8. 30808
    “…PLEASE ACKNOWLEDGE ALL FUNDING AGENCIES BY CHECKING THE APPLICABLE BOXES BELOW: Other PLEASE INDICATE YOUR SOURCE OF FUNDING; NSERC DISCLOSURE OF INTEREST: None Declared…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  9. 30809
    “…PLEASE ACKNOWLEDGE ALL FUNDING AGENCIES BY CHECKING THE APPLICABLE BOXES BELOW: Other PLEASE INDICATE YOUR SOURCE OF FUNDING; MEDTEQ DISCLOSURE OF INTEREST: M. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  10. 30810
    “…PLEASE ACKNOWLEDGE ALL FUNDING AGENCIES BY CHECKING THE APPLICABLE BOXES BELOW: NRC DISCLOSURE OF INTEREST: None Declared…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  11. 30811
    “…PLEASE ACKNOWLEDGE ALL FUNDING AGENCIES BY CHECKING THE APPLICABLE BOXES BELOW: CIHR, Other PLEASE INDICATE YOUR SOURCE OF FUNDING; Fonds de Recherche du Québec en Santé DISCLOSURE OF INTEREST: None Declared…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  12. 30812
    “…PLEASE ACKNOWLEDGE ALL FUNDING AGENCIES BY CHECKING THE APPLICABLE BOXES BELOW: None DISCLOSURE OF INTEREST: None Declared…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  13. 30813
    “…While presenting autologous M(IL4) transfer as a novel approach for IBD, a much fuller understanding of the phenotype and function of M(IL4)s (and sub-populations therein) is required before this would become a therapeutic option PLEASE ACKNOWLEDGE ALL FUNDING AGENCIES BY CHECKING THE APPLICABLE BOXES BELOW: CAG DISCLOSURE OF INTEREST: None Declared…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  14. 30814
    “…PLEASE ACKNOWLEDGE ALL FUNDING AGENCIES BY CHECKING THE APPLICABLE BOXES BELOW: Other PLEASE INDICATE YOUR SOURCE OF FUNDING; The study was supported by a "Fonds de Recherche du Québec Santé" career development award (Daniel von Renteln) and a University of Montreal student award “PRogramme d’Excellence en Médecine pour l’Initiation En Recherche – PREMIER (Claire Haumesser). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  15. 30815
  16. 30816
  17. 30817
    “…The rs10848087 G > A was significantly associated with increased risk of EOC in individuals with metastasis, FIGO stage I and III, low and high pathological grade, tumor numbers ≤ 3 and > 3, tumor size > 3 cm and ≤ 3 cm, pregnant more than 3 times, pre-menopausal status, and strong positive expression of ER (estrogen receptor), PR (progesterone receptor), PAX8 (paired-box 8), wild-type p53 (tumor protein 53), WT1 (Wilm’s tumor gene), P16 (cyclin-dependent kinase inhibitor 2A). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  18. 30818
  19. 30819
  20. 30820
    “…Broad clinical syndromes associated with COVID-19 were classified as a cerebrovascular event (defined as an acute ischaemic, haemorrhagic, or thrombotic vascular event involving the brain parenchyma or subarachnoid space), altered mental status (defined as an acute alteration in personality, behaviour, cognition, or consciousness), peripheral neurology (defined as involving nerve roots, peripheral nerves, neuromuscular junction, or muscle), or other (with free text boxes for those not meeting these syndromic presentations). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
Herramientas de búsqueda: RSS